Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Drugs Made In America Acquisition Corp. - Rights Stock Price, Quotes and Forecasts | NASDAQ:DMAAR | Benzinga

Explore Drugs Made In America Acquisition Corp. - Rights stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for DMAAR.

Open	$0.13
Close	$0.13
Volume / Avg.	437.00 / 242.68K
Day Range	$0.13 - $0.13
52 Wk Range	0.09 - 0.17
Market Cap	-
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	49
Short Interest	-
Days to Cover	1

Recent News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	$0.13
Close	$0.13
Volume / Avg.	437.00 / 242.68K
Day Range	$0.13 - $0.13
52 Wk Range	0.09 - 0.17
Market Cap	-
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	49
Short Interest	-
Days to Cover	1

About Drugs Made In America Acquisition Corp.

Sector

N/A

Industry

N/A

Got Questions? Ask

How is DMAAR's ROE trending?

What is DMAAR's current market cap?

What is DMAAR's dividend yield?

What is DMAAR's P/E ratio?

What is DMAAR's Sharpe ratio?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Drugs Made In America Acquisition Corp. - Rights (DMAAR) stock?

You can purchase shares of Drugs Made In America Acquisition Corp. - Rights (NASDAQ:DMAAR) through any online brokerage.

View our list of the best stock brokerages

Who are Drugs Made In America Acquisition Corp. - Rights (DMAAR) competitors?

There are no as such competitors for Drugs Made In America Acquisition Corp. - Rights.

What is the forecast, or price target, for Drugs Made In America Acquisition Corp. - Rights (DMAAR) stock?

There is no analysis for Drugs Made In America Acquisition Corp. - Rights to provide a consensus price target.

What is the current price for Drugs Made In America Acquisition Corp. - Rights (DMAAR)?

The stock price for Drugs Made In America Acquisition Corp. - Rights (NASDAQ: DMAAR) is $0.13 last updated April 15, 2025 at 11:21 AM EDT.

Does Drugs Made In America Acquisition Corp. - Rights (DMAAR) pay a dividend?

There are no upcoming dividends for Drugs Made In America Acquisition Corp. - Rights.

When is Drugs Made In America Acquisition Corp. - Rights (NASDAQ:DMAAR) reporting earnings?

Drugs Made In America Acquisition Corp. - Rights does not have any upcoming earnings scheduled.

Is Drugs Made In America Acquisition Corp. - Rights (DMAAR) going to split?

There is no upcoming split for Drugs Made In America Acquisition Corp. - Rights.

Comments

Drugs Made In America Acquisition Corp. - Rights Stock Price, Quotes and Forecasts

Drugs Made In America Acquisition Corp. - Rights (DMAAR) Forecast